Preoperative Evaluation of Microcirculation for Prediction of Complications After Cardiac Surgery (MONS)

February 9, 2023 updated by: University Hospital, Angers

L'Etude préopératoire de la Microcirculation Pour la prédiction Des Complications après Une Chirurgie Cardiaque Sous Circulation Extracorporelle.

Cardiac surgery is responsible for many complications. Microcirculation is involved in many of them. The objective of this study is to prospectively investigate the prognostic value of preoperative microcirculatory assessment in patients scheduled for cardiac surgery with CPB for the occurrence of postoperative complications.

Microvascular dysfunction is suspected of being involved in postoperative psycho-cognitive decline. The influence of microcirculation on the evolution of psycho-cognitive assessment is also analyzed in this study.

Study Overview

Detailed Description

Eligible patients are included during the preoperative assessment. Written consent is signed after complete explanation of the protocol.

Patient characteristics as treatments, medical history, and EuroSCORE II are registered. Moreover, intraoperative data is collected. Psycho-cognitive and functional evaluation is made preoperatively.

Microcirculation is evaluated for each patient before surgery. Complications are registered at the end of hospital stay. Psycho-cognitive and functional evaluation is repeated by call 30 days after the surgery.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France, 49933
        • UH Angers

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Valvular ou coronary elective cardiac surgery under cardiopulmonary bypass
  • Fair skin phototype
  • Ability to understand the study goal, no dementia.
  • Affiliation to the French National Healthcare System
  • Voluntary patients who have signed an informed consent

Exclusion Criteria:

  • Emergency surgery
  • Multiple procedures, combined surgery (valvular and coronary)
  • Single aortic surgery
  • Patient already included in the study (second surgery)
  • Patients protected by decision of law

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Microvascular reactivity evaluation

Patients referred for a preoperative arterial palmar arches assessment before cardiac valvular or coronary surgery.

Intervention is measurement of microvascular reactivity with a laser speckle contrast imaging before surgery.

Microcirculation will be evaluated for each patient before surgery with a laser speckle contrast imaging (LSCI) placed on the forearm. Tests will be performed for evaluation of endothelium reactivity: Iontophoresis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complication
Time Frame: 30 postoperative days

Composite criteria and include microcirculation postoperative complications:

  • Late surgical re-intervention (greater than 12 hours) for evacuation of pericardial effusion (seeps),
  • Surgical wound disunion or surgical site infection,
  • Organ failure: SOFA score greater than 2 at 48h,
  • Postoperative confusion: assessed using the Confusion Assessment Method (CAM) or the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU),
  • Acute renal failure ≥ stage 2 according to the KDIGO classification,
  • Acute lung injury defined as PaO2 <55mmHg in ambient air, PaO2 / FiO2 ratio <250 or Pulse Oxygen Saturation (SpO2) <90% and need for oxygen therapy,
  • Atrial fibrillation (excluding patients with permanent Atrial Fibrillation preoperatively),
  • Hepatocellular injury (Cytolysis > 10N, Prothrombin rate and Factor V decreased < 60%).
30 postoperative days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of degree of disability
Time Frame: Inclusion and 30 days after surgery
Change of modified Rankin scale
Inclusion and 30 days after surgery
Functional evolution
Time Frame: Inclusion and 30 days after surgery
Change of ADL score
Inclusion and 30 days after surgery
Mood evolution
Time Frame: Inclusion and 30 days after surgery
Change of brief Geriatric Depression Scale
Inclusion and 30 days after surgery
Cognitive evolution
Time Frame: Inclusion and 30 days after surgery
Change of Mc Nair test
Inclusion and 30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 14, 2019

Primary Completion (ACTUAL)

April 26, 2019

Study Completion (ACTUAL)

April 26, 2019

Study Registration Dates

First Submitted

July 30, 2018

First Submitted That Met QC Criteria

August 10, 2018

First Posted (ACTUAL)

August 15, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 10, 2023

Last Update Submitted That Met QC Criteria

February 9, 2023

Last Verified

June 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Extracorporeal Circulation; Complications

Clinical Trials on Microvascular reactivity evaluation

3
Subscribe